Cisen Pharmaceutical Co., Ltd. (SHA:603367)
17.28
+0.13 (0.76%)
Feb 24, 2026, 3:00 PM CST
Cisen Pharmaceutical Revenue
Cisen Pharmaceutical had revenue of 844.01M CNY in the quarter ending September 30, 2025, a decrease of -9.41%. This brings the company's revenue in the last twelve months to 3.56B, down -16.26% year-over-year. In the year 2024, Cisen Pharmaceutical had annual revenue of 3.98B, down -10.77%.
Revenue (ttm)
3.56B
Revenue Growth
-16.26%
P/S Ratio
2.18
Revenue / Employee
1.08M
Employees
3,302
Market Cap
7.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.98B | -480.78M | -10.77% |
| Dec 31, 2023 | 4.46B | 396.26M | 9.75% |
| Dec 31, 2022 | 4.07B | 283.50M | 7.49% |
| Dec 31, 2021 | 3.78B | 108.43M | 2.95% |
| Dec 31, 2020 | 3.67B | -438.63M | -10.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Shandong Wit Dyne Health | 2.36B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Jiuzhitang | 1.94B |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| Hunan Er-Kang Pharmaceutical | 1.29B |